Contrast Media The Product - Sanochemia
Contrast Media The Product - Sanochemia
Contrast Media The Product - Sanochemia
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
A Company with Attractive <strong>Product</strong>s<br />
Neuropathic Pain<br />
<strong>The</strong> <strong>Product</strong> – Galantamine Gel for DPN<br />
<strong>Product</strong> advantages<br />
• Topical (non-systemic) administration by the patient<br />
• Favourable side effect profile<br />
Competitive edge<br />
• Existing API registration for galantamine<br />
Status quo / prospects<br />
• Phase IIa study of liposomal galantamine successfully concluded (Feb. 2007)<br />
• 2008: optimised gel formulation in clinical development with the aim of further<br />
increasing the bio-availability of galantamine at the site of action (in deeper skin and<br />
tissue layers)<br />
• Peak sales: EUR 300m. (forecast 3 - 5 years after launch)<br />
16
Change language